Cutis. 2005 Dec;76(6 Suppl):13-8.

Improved clinical outcomes with moisturization in dermatologic disease.

Source

Pediatric Dermatology of North Texas, PA, Grapevine, USA.

Abstract

Controlled clinical studies have provided strong evidence that moisturizers not only enhance the efficacy of topical corticosteroids in patients with atopic dermatitis but also may prevent disease reexacerbation. Furthermore, moisturizers have been shown to have a steroid-sparing effect both in patients with atopic dermatitis and in those with psoriasis. In particular, certain lipid-dominant moisturizers have been shown to significantly (P<.05) improve the condition of the skin based on objectively assessed changes in clinical parameters when used by patients with various dermatoses. Although further research is warranted, moisturizers represent a valuable first-line treatment option for many dermatologic diseases and confer a number of important therapeutic benefits beyond mere cosmetic effects.

PMID:: 16869177; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Education

New England Research Institutes Inc.

Medical

Psoriasis - MedlinePlus Health Information

Supplemental Content

Related citations

Review Impaired skin barrier function in dermatologic disease and repair with moisturization. [Cutis. 2005]
Review Impaired skin barrier function in dermatologic disease and repair with moisturization.
Lebwohl M, Herrmann LG. Cutis. 2005 Dec; 76(6 Suppl):7-12.
Review The use of therapeutic moisturizers in various dermatologic disorders. [Cutis. 2001]
Review The use of therapeutic moisturizers in various dermatologic disorders.
Bikowski J. Cutis. 2001 Dec; 68(5 Suppl):3-11.
Review Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. [Am J Clin Dermatol. 2003]
Review Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders.
Lodén M. Am J Clin Dermatol. 2003; 4(11):771-88.
Use of moisturizers in dermatologic disease: the role of healthcare providers in optimizing treatment outcomes. [Cutis. 2005]
Use of moisturizers in dermatologic disease: the role of healthcare providers in optimizing treatment outcomes.
Nicol NH. Cutis. 2005 Dec; 76(6 Suppl):26-31.
Review Moisturizers: what they are and how they work. [Skin Therapy Lett. 2001]
Review Moisturizers: what they are and how they work.
Lynde CW. Skin Therapy Lett. 2001 Dec; 6(13):3-5.

See reviews... See all...

Cited by 1 PubMed Central article

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis. [J Clin Aesthet Dermatol. 2011]
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis.
Emer JJ, Frankel A, Sohn A, Lebwohl M. J Clin Aesthet Dermatol. 2011 Feb; 4(2):28-39.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Improved clinical outcomes with moisturization in dermatologic disease.
Improved clinical outcomes with moisturization in dermatologic disease.
Cutis. 2005 Dec ;76(6 Suppl):13-8.

PubMed
5% topical imiquimod tolerance in transplant recipients.
5% topical imiquimod tolerance in transplant recipients.
Dermatology. 2007 ;215(2):130-3.

PubMed
Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic ker...
Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").
J Am Acad Dermatol. 2000 Jan ;42(1 Pt 2):11-7.

PubMed
Long-term clinical outcomes following treatment of actinic keratosis with imiqui...
Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.
Dermatol Surg. 2005 Jun ;31(6):659-64.

PubMed
Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized ...
Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
J Am Acad Dermatol. 2006 Sep ;55(3):537-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: